Nephros Inc (NEPH)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $32.61M
Last updated: Nov 17, 2026 at 4:10 PM ET
Nephros Inc (NEPH) Statistics
Nephros (NEPH) has a market cap of $32.61M and an enterprise value of $28.41M. Revenue grew 20.36% over the last 12 months from the 12 months before. It holds $4.20M more cash than debt, 12.87% of its market cap.
Total Valuation
Enterprise value is 12.87% below the market cap, as cash exceeds debt.
| Market Cap | $32.61M |
|---|---|
| Enterprise Value | $28.41M |
| Latest price (Nov 17, 2026) | $2.90 |
Key Dates
The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 10, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.5x and 2.5x.
| P/E Ratio | 22.3x |
|---|---|
| Forward P/E | 16.4x |
| P/S Ratio | 1.5x |
| Forward P/S | 1.5x |
| P/B Ratio | 2.5x |
| P/TBV Ratio | 2.8x |
| PEG Ratio | 0.5 |
Enterprise Valuation
Counting debt and cash, the company is valued at 14.6x EBITDA.
| EV / Earnings | 14.8x |
|---|---|
| EV / Sales | 1.3x |
| EV / EBITDA | 14.6x |
Price Statistics
The stock is down 34.09% over 52 weeks and trades 20.11% below its 50-day average.
| Beta (1Y) | 0.95 |
|---|---|
| 52-Week Change | -34.09% |
| 1-Month Change | -21.20% |
| 3-Month Change | -39.08% |
| 6-Month Change | -20.11% |
| 5-Year Change | -59.57% |
| Total Return (1Y) | -34.09% |
| Total Return (3Y CAGR) | +12.26% |
| Total Return (5Y CAGR) | -17.16% |
| Return vs SPY (1Y) | -58.35% |
| Max Drawdown (1Y) | -51.94% |
| Max Drawdown (3Y) | -65.06% |
| Sharpe Ratio (1Y) | -0.78 |
| Correlation with SPY (1Y) | 0.16 |
| 50-Day Average | $3.63 |
| 200-Day Average | $3.58 |
| 52-Week Range | $2.66 to $6.42 |
| RSI (14 Days) | 38.8 |
| Average Volume (20 Days) | 75.19K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 5.50x current liabilities, and total debt is 0.03x shareholder equity.
| Current Ratio | 5.50x |
|---|---|
| Quick Ratio | 3.45x |
| Debt / Equity | 0.03x |
| Debt / EBITDA | 0.19x |
| Interest Coverage | 1068.00x |
Returns and Efficiency
Return on invested capital is 10.76% over the last 12 months, against a 5-year average of -5.43%.
| Return on Equity (ROE) | 15.29% |
|---|---|
| Return on Assets (ROA) | 12.54% |
| Return on Invested Capital (ROIC) | 10.76% |
| ROE (5Y Average) | -33.28% |
| ROA (5Y Average) | -18.08% |
| ROIC (5Y Average) | -5.43% |
| Asset Turnover | 1.51x |
| Inventory Turnover | 1.79x |
| Receivables Turnover | 5.62x |
| Cash Conversion Cycle | 208 days |
Taxes
Income tax took 0.68% of pretax income over the last 12 months.
| Income Tax (TTM) | $13.00K |
|---|---|
| Effective Tax Rate | 0.68% |
Scores
NEPH has an Altman Z-Score of -3.43, in the distress zone below 1.81, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -3.43 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $21.58M over the last 12 months.
| Revenue | $21.58M |
|---|---|
| Revenue Growth (YoY) | +20.36% |
| Gross Profit | $13.07M |
| Operating Income | $1.83M |
| Pretax Income | $1.92M |
| Net Income | $1.92M |
| Reported EPS (TTM) | $0.13 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 82.03% of the $15.30M in total assets.
| Cash and Equivalents | $4.55M |
|---|---|
| Total Debt | $348.00K |
| Net Cash | $4.20M |
| Net Cash Per Share | $0.39 |
| Working Capital | $10.85M |
| Shareholder Equity | $12.55M |
| Book Value Per Share | $1.16 |
| Tangible Book Value | $11.36M |
| Tangible Book Per Share | $1.05 |
| Total Assets | $15.30M |
| Total Liabilities | $2.76M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$910.00K |
|---|---|
| FCF Per Share | -$0.08 |
| Depreciation and Amortization | $118.00K |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 8.48%, against a 5-year average of -16.07%.
| Gross Margin | 60.55% |
|---|---|
| Operating Margin | 8.48% |
| Pretax Margin | 8.92% |
| Net Margin | 8.89% |
| Gross Margin (5Y Average) | 57.01% |
| Operating Margin (5Y Average) | -16.07% |
| Net Margin (5Y Average) | -22.65% |
Growth
Revenue grew 23.50% a year over 3 years.
| Revenue Growth (3Y CAGR) | +23.50% |
|---|---|
| Revenue Growth (5Y CAGR) | +17.02% |
| Book Value Per Share Growth (2Y CAGR) | +8.32% |
| Tangible Book Per Share Growth (2Y CAGR) | +11.36% |
Dividends and Yields
NEPH does not pay a dividend.
| Earnings Yield | 4.48% |
|---|---|
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 1-for-9 reverse split on Jul 10, 2019.
| Last Split Date | Jul 10, 2019 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:9 |
Peer Position
Against 11 similar companies, NEPH has the 8th highest P/S.
P/S RatioPeer median 2.9x
ROICPeer median -10.25%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +3.14%
| P/S Ratio | 1.5x vs 2.9x median |
|---|---|
| ROIC | 10.76% vs -10.25% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +20.36% vs +3.14% median |
Analyst Forecast
Consensus estimates put revenue growth at 17.32% and EPS growth at 41.42% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +17.32% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +41.42% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About NEPH
What is NEPH's market cap?
Nephros has a market cap of $32.61M. Its enterprise value, which adds debt and subtracts cash, is $28.41M.
What is NEPH's P/E ratio?
Nephros has a trailing P/E ratio of 22.3x and a forward P/E of 16.4x.
How many shares of NEPH are outstanding?
Nephros has 10.86M shares outstanding. The count is up 2.37% from a year earlier.
Does NEPH pay a dividend?
No. Nephros does not pay a dividend.
How much debt does NEPH have?
Nephros has $348.00K of total debt and $4.55M of cash and equivalents, a net cash position of $4.20M.
NEPH pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors